Peroxiredoxin 4 Ameliorates T-2 Toxin-Induced Growth Retardation in GH3 Cells by Inhibiting Oxidative Stress and Apoptosis
Molecules · 2024
DOI: 10.3390/molecules29235491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Qirong Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Animal Nutrition and Feed Science, School of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan …. Hauptthemen laut MEDLINE: T-2 Toxin, Peroxiredoxins, Apoptosis, Oxidative Stress. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), Open Project Funding of the State Key Laboratory of Biocatalysis and Enzyme Engineering, State Key Laboratory of Biocatalysis and Enzyme Engineering.
Abstract (Originalsprache)
T-2 toxin, a highly toxic type A trichothecene, is a secondary fungal metabolite produced by various Fusarium species. The consumption of food and feed contaminated with T-2 toxin is a major factor contributing to growth retardation, posing significant risks to both human and animal health. However, the specific targets and mechanisms that mitigate T-2 toxin-induced growth retardation remain unclear. In this study, transcriptomic analysis was employed to identify key differentially expressed genes associated with the alleviation of T-2 toxin-induced growth retardation. Peroxiredoxin 4 (PRDX4), a gene linked to oxidative stress and apoptosis, was found to be one of the most downregulated in T-2 toxin-treated GH3 cells, an in vitro model of growth retardation. The experiments demonstrated that T-2 toxin significantly increased reactive oxygen species’ production, apoptosis, and cell cycle arrest while reducing the activity of antioxidant enzymes (superoxide dismutase and glutathione peroxidase) and PRDX4 expression in GH3 cells. Furthermore, PRDX4 silencing exacerbated T-2 toxin-induced oxidative stress and apoptosis, whereas PRDX4 overexpression effectively mitigated these effects. These findings highlight the protective role of PRDX4 in counteracting T-2 toxin-induced oxidative stress and apoptosis, suggesting that PRDX4 can serve as a therapeutic target for the treatment of T-2 toxin-induced growth retardation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Animal Nutrition and Feed Science, School of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan 430023, China.
- State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan 430062, China.
- National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.
ORCID-Profile: Xu Wang
Förderung
- National Natural Science Foundation of China (NSFC)
- Open Project Funding of the State Key Laboratory of Biocatalysis and Enzyme Engineering
- State Key Laboratory of Biocatalysis and Enzyme Engineering
Zitieren
APA
Lu, Q., Zhu, Y., Wang, L., Mei, M., Qiu, Y., Liu, Y., Fu, S., Xiong, J., Guo, P., Wu, Z., & Wang, X. (2024). Peroxiredoxin 4 Ameliorates T-2 Toxin-Induced Growth Retardation in GH3 Cells by Inhibiting Oxidative Stress and Apoptosis. Molecules. https://doi.org/10.3390/molecules29235491
Vancouver
Lu Q, Zhu Y, Wang L, Mei M, Qiu Y, Liu Y, et al. Peroxiredoxin 4 Ameliorates T-2 Toxin-Induced Growth Retardation in GH3 Cells by Inhibiting Oxidative Stress and Apoptosis. Molecules. 2024. doi:10.3390/molecules29235491
BibTeX
@article{Lu2024,
author = {Lu, Qirong and Zhu, Yi and Wang, Luyao and Mei, Meng and Qiu, Yinsheng and Liu, Yu and Fu, Shulin and Xiong, Jianglin and Guo, Pu and Wu, Zhongyuan and Wang, Xu},
title = {Peroxiredoxin 4 Ameliorates T-2 Toxin-Induced Growth Retardation in GH3 Cells by Inhibiting Oxidative Stress and Apoptosis},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29235491}
}
EUVIMED